ArticleCancers2024

Immune-Cell-Derived Exosomes as a Potential Novel Tool to Investigate Immune Responsiveness in SCLC Patients: A Proof-of-Concept Study.

Luisa Amato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.